Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models-Reference-Cited by-同舟云学术

Can we predict pathology without surgery? Weighing the added value of multiparametric MRI and whole prostate radiomics in integrative machine learning models

Published:2024-03-20 Issue:10 Volume:34 Page:6241-6253
ISSN:1432-1084
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Marvaso Giulia,Isaksson Lars Johannes,Zaffaroni Mattia,Vincini Maria Giulia^ORCID,Summers Paul Eugene,Pepa Matteo,Corrao Giulia,Mazzola Giovanni Carlo,Rotondi Marco,Mastroleo Federico,Raimondi Sara,Alessi Sarah,Pricolo Paola,Luzzago Stefano,Mistretta Francesco Alessandro,Ferro Matteo,Cattani Federica,Ceci Francesco,Musi Gennaro,De Cobelli Ottavio,Cremonesi Marta,Gandini Sara,La Torre Davide,Orecchia Roberto,Petralia Giuseppe,Jereczek-Fossa Barbara Alicja

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00330-024-10699-3.pdf

Reference75 articles.

1. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492

2. Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660

3. Hamdy FC, Donovan JL, Lane JA et al (2016) 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 375:1415–1424. https://doi.org/10.1056/NEJMoa1606220

4. Mottet N, van den Bergh RCN, Briers E et al (2021) EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 79:243–262. https://doi.org/10.1016/j.eururo.2020.09.042

5. Schaeffer E, An Y, Barocas D et al (2022) NCCN Guidelines Version 1.2023 Prostate Cancer. In: Available from: https://www.nccn.org/home/. Accessed 1 Mar 2023